Jenburkt Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 ,inter alia, to consider and approve standalone unaudited financial results for the quarter and nine months ended On 31st December, 2025.
Jenburkt Pharmaceuticals Ltd Press Release Jan 28 2026
Filed with BSE · · 1 page · English
Release
Jenburkt Pharmaceuticals Ltd on 6ix
Earlier from Jenburkt Pharmaceuticals
- Jenburkt Pharmaceuticals Ltd Press Release Jan 07 2026
- Jenburkt Pharmaceuticals Ltd Press Release Dec 15 2025
- Jenburkt Pharmaceuticals Ltd Press Release Oct 29 2025
- Jenburkt Pharmaceuticals Ltd Press Release Oct 28 2025
- Jenburkt Pharmaceuticals Ltd Press Release Oct 09 2025
Later from Jenburkt Pharmaceuticals
- Jenburkt Pharmaceuticals Ltd Press Release Feb 03 2026
- Jenburkt Pharmaceuticals Ltd Press Release Feb 04 2026
- Jenburkt Pharmaceuticals Ltd Press Release Mar 23 2026
- Jenburkt Pharmaceuticals Ltd Press Release Apr 07 2026
- Jenburkt Pharmaceuticals Ltd Press Release Apr 28 2026
Follow Jenburkt Pharmaceuticals into a list and get an email when it puts out news.
Follow Jenburkt Pharmaceuticals